255 related articles for article (PubMed ID: 18382996)
21. [Birth defects associated with increased nuchal translucency].
Mendoza-Caamal EC; Grether-González P; Hernández-Gómez M; Guzmán-Huerta M; Aguinaga-Ríos M
Ginecol Obstet Mex; 2010 Oct; 78(10):533-9. PubMed ID: 21966770
[TBL] [Abstract][Full Text] [Related]
22. Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses.
Hyett J; Moscoso G; Nicolaides K
Am J Med Genet; 1997 Mar; 69(2):207-16. PubMed ID: 9056563
[TBL] [Abstract][Full Text] [Related]
23. First-trimester measurement of the ductus venosus pulsatility index and the prediction of congenital heart defects.
Timmerman E; Clur SA; Pajkrt E; Bilardo CM
Ultrasound Obstet Gynecol; 2010 Dec; 36(6):668-75. PubMed ID: 20617506
[TBL] [Abstract][Full Text] [Related]
24. Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects.
Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ
Prenat Diagn; 2009 Jun; 29(6):570-7. PubMed ID: 19266536
[TBL] [Abstract][Full Text] [Related]
25. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
[TBL] [Abstract][Full Text] [Related]
26. Cardiac function in trisomy 21 fetuses.
Clur SA; Oude Rengerink K; Ottenkamp J; Bilardo CM
Ultrasound Obstet Gynecol; 2011 Feb; 37(2):163-71. PubMed ID: 20814928
[TBL] [Abstract][Full Text] [Related]
27. First trimester predictors of adverse pregnancy outcomes.
Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
[TBL] [Abstract][Full Text] [Related]
28. Reliability of the first-trimester cardiac scan by ultrasound-trained obstetricians with high-frequency transabdominal probes in fetuses with increased nuchal translucency.
Bellotti M; Fesslova V; De Gasperi C; Rognoni G; Bee V; Zucca I; Cappellini A; Bulfamante G; Lombardi CM
Ultrasound Obstet Gynecol; 2010 Sep; 36(3):272-8. PubMed ID: 20499407
[TBL] [Abstract][Full Text] [Related]
29. The nuchal translucency and the fetal heart: a literature review.
Clur SA; Ottenkamp J; Bilardo CM
Prenat Diagn; 2009 Aug; 29(8):739-48. PubMed ID: 19399754
[TBL] [Abstract][Full Text] [Related]
30. Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16,383 fetuses.
Westin M; Saltvedt S; Bergman G; Almström H; Grunewald C; Valentin L
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):632-9. PubMed ID: 16715530
[TBL] [Abstract][Full Text] [Related]
31. Increased nuchal translucency and congenital heart defects in a low-risk population.
Hafner E; Schuller T; Metzenbauer M; Schuchter K; Philipp K
Prenat Diagn; 2003 Dec; 23(12):985-9. PubMed ID: 14663835
[TBL] [Abstract][Full Text] [Related]
32. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation.
Maiz N; Valencia C; Emmanuel EE; Staboulidou I; Nicolaides KH
Obstet Gynecol; 2008 Sep; 112(3):598-605. PubMed ID: 18757658
[TBL] [Abstract][Full Text] [Related]
33. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan.
Becker R; Wegner RD
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):613-8. PubMed ID: 16570262
[TBL] [Abstract][Full Text] [Related]
34. Intracardiac Doppler assessment of left valve inflow in first-trimester fetuses with increased nuchal translucency: preliminary observations in trisomy 21.
Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
Ultrasound Obstet Gynecol; 2006 Jul; 28(1):77-81. PubMed ID: 16795127
[TBL] [Abstract][Full Text] [Related]
35. Audit of 10 years of referrals for fetal echocardiography.
Clur SA; Van Brussel PM; Mathijssen IB; Pajkrt E; Ottenkamp J; Bilardo CM
Prenat Diagn; 2011 Dec; 31(12):1134-40. PubMed ID: 21915886
[TBL] [Abstract][Full Text] [Related]
36. Fetal echocardiography at the time of the nuchal translucency scan.
Lombardi CM; Bellotti M; Fesslova V; Cappellini A
Ultrasound Obstet Gynecol; 2007 Mar; 29(3):249-57. PubMed ID: 17318942
[TBL] [Abstract][Full Text] [Related]
37. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype.
Ghi T; Huggon IC; Zosmer N; Nicolaides KH
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):610-4. PubMed ID: 11844199
[TBL] [Abstract][Full Text] [Related]
38. Is the addition of the ductus venosus useful when screening for aneuploidy and congenital heart disease in fetuses with normal nuchal translucency?
Prats P; Ferrer Q; Comas C; Rodríguez I
Fetal Diagn Ther; 2012; 32(1-2):138-43. PubMed ID: 22585666
[TBL] [Abstract][Full Text] [Related]
39. Male gender as a favorable prognostic factor in pregnancies with enlarged nuchal translucency.
Timmerman E; Pajkrt E; Bilardo CM
Ultrasound Obstet Gynecol; 2009 Oct; 34(4):373-8. PubMed ID: 19618399
[TBL] [Abstract][Full Text] [Related]
40. Nuchal translucency and cystic hygroma colli in screening for fetal major congenital heart defects in a series of 12,910 euploid pregnancies.
Sananes N; Guigue V; Kohler M; Bouffet N; Cancellier M; Hornecker F; Hunsinger MC; Kohler A; Mager C; Neumann M; Schmerber E; Tanghe M; Nisand I; Favre R
Ultrasound Obstet Gynecol; 2010 Mar; 35(3):273-9. PubMed ID: 20069678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
